We are live on ! Find out more
VIGL

Vigil Neuroscience

Delisted

VIGL was delisted on the 4th of August, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$57.1M
NV
2
Northpond Ventures
Maryland
$41.3M
AG
3
Artal Group
Luxembourg
$22M
Citadel Advisors
4
Citadel Advisors
Florida
$21.2M -$23.8K -2,120 -0.1%
DM
5
Deerfield Management
New York
$20.1M
DTC
6
Deep Track Capital
Connecticut
$19.8M -$888K -79,037 -4%
BI
7
BVF Inc
California
$17.8M
Vanguard Group
8
Vanguard Group
Pennsylvania
$7.13M -$94.4K -8,400 -1%
CAM
9
Cormorant Asset Management
Massachusetts
$6.04M
PBPIA
10
Pivotal bioVenture Partners Investment Advisor
California
$5.49M
RSCM
11
Rock Springs Capital Management
Maryland
$4.62M
O
12
OrbiMed
New York
$4.39M
HMC
13
Harvard Management Company
Massachusetts
$2.83M
TOCUITCONY
14
Trustees of Columbia University in the City of New York
New York
$1.89M
LGM
15
Logos Global Management
California
$1.84M
DCM
16
DAFNA Capital Management
California
$1.69M +$38.9K +3,462 +2%
LCM
17
Laurion Capital Management
New York
$1.27M
Geode Capital Management
18
Geode Capital Management
Massachusetts
$1.1M +$97K +8,625 +8%
Barclays
19
Barclays
United Kingdom
$1.02M -$18.5K -1,645 -2%
BlackRock
20
BlackRock
New York
$999K -$3.43K -305 -0.3%
Citigroup
21
Citigroup
New York
$895K -$28.4K -2,529 -3%
Fidelity Investments
22
Fidelity Investments
Massachusetts
$849K +$832 +74 +0.1%
Millennium Management
23
Millennium Management
New York
$699K +$802K +71,381 New
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$575K +$352K +31,343 +114%
Morgan Stanley
25
Morgan Stanley
New York
$571K +$554K +49,252 +542%